HHC
RMD icon

Hutchin Hill Capital’s ResMed RMD Stock Holding History

Hutchin Hill Capital’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-18,900
Closed -$1.2M – 693
2016
Q2 		$1.2M Buy
+18,900
New +$1.11M 0.04% 285
2013
Q3 		– Sell
-5,600
Closed -$253K – 563
2013
Q2 		$253K Buy
+5,600
New +$266K 0.03% 359

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Hutchin Hill Capital's RMD Position: Q3 2016 in Review

Hutchin Hill Capital sold out of ResMed (RMD) in Q3 2016, closing a stake of 18,900 shares — an estimated $1.2M sold.

Hutchin Hill Capital first reported a position in RMD in Q2 2013 and held it in 2 quarters. The position peaked at $1.2M in Q2 2016. 373 funds tracked by Wall St. Rank hold RMD as of Q3 2016.

  • Hutchin Hill Capital reported no remaining ResMed position as of Q3 2016 after selling out during the quarter.
  • Hutchin Hill Capital sold 18,900 ResMed shares in Q3 2016, an estimated $1.2M.
  • Hutchin Hill Capital first reported a position in ResMed in Q2 2013 and held it in 2 quarters.
  • Hutchin Hill Capital's ResMed position peaked at $1.2M in Q2 2016.
  • 373 funds tracked by Wall St. Rank held ResMed as of Q3 2016.

Based on Hutchin Hill Capital's 13F filing for Q3 2016, filed 14 Nov 2016.